Cargando…
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues
PURPOSE OF THE REVIEW: As the number of cancer survivors increases due to early screening and modern (antineoplastic) treatments, cancer treatment associated cardiotoxicity (CTAC) is becoming an increasing health burden that affects survival and quality of life among cancer survivors. Thus, clinicia...
Autores principales: | Bracun, Valentina, Aboumsallem, Joseph Pierre, van der Meer, Peter, de Boer, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280346/ https://www.ncbi.nlm.nih.gov/pubmed/32514994 http://dx.doi.org/10.1007/s11912-020-00930-x |
Ejemplares similares
-
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications
por: Cuomo, Alessandra, et al.
Publicado: (2020) -
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population
por: Asokan, Ishan, et al.
Publicado: (2020) -
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
por: Sadler, Diego, et al.
Publicado: (2021) -
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation
por: Sestier, Maude, et al.
Publicado: (2021) -
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2021)